Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

myo-Inositol dehydrogenase and scyllo-inositol dehydrogenase from Lactobacillus casei BL23 bind their substrates in very different orientations.

Aamudalapalli HB, Bertwistle D, Palmer DRJ, Sanders DAR.

Biochim Biophys Acta Proteins Proteom. 2018 Nov;1866(11):1115-1124. doi: 10.1016/j.bbapap.2018.08.011. Epub 2018 Aug 30.

PMID:
30282609
2.

Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States.

Zuluaga-Sanchez S, Hess LM, Wolowacz SE, D'yachkova Y, Hawe E, Vickers AD, Kaye JA, Bertwistle D.

Sarcoma. 2018 Mar 26;2018:6703963. doi: 10.1155/2018/6703963. eCollection 2018.

3.

Purification, crystallization and room-temperature X-ray diffraction of inositol dehydrogenase LcIDH2 from Lactobacillus casei BL23.

Bertwistle D, Vogt L, Aamudalapalli HB, Palmer DR, Sanders DA.

Acta Crystallogr F Struct Biol Commun. 2014 Jul;70(Pt 7):979-83. doi: 10.1107/S2053230X14011595. Epub 2014 Jun 19.

4.

Converting NAD-specific inositol dehydrogenase to an efficient NADP-selective catalyst, with a surprising twist.

Zheng H, Bertwistle D, Sanders DA, Palmer DR.

Biochemistry. 2013 Aug 27;52(34):5876-83. doi: 10.1021/bi400821s. Epub 2013 Aug 16.

PMID:
23952058
5.

Vortex core switching by coherent excitation with single in-plane magnetic field pulses.

Weigand M, Van Waeyenberge B, Vansteenkiste A, Curcic M, Sackmann V, Stoll H, Tyliszczak T, Kaznatcheev K, Bertwistle D, Woltersdorf G, Back CH, Sch├╝tz G.

Phys Rev Lett. 2009 Feb 20;102(7):077201. Epub 2009 Feb 17.

PMID:
19257708
6.

Nanoscale chemical imaging of the reduction behavior of a single catalyst particle.

de Smit E, Swart I, Creemer JF, Karunakaran C, Bertwistle D, Zandbergen HW, de Groot FM, Weckhuysen BM.

Angew Chem Int Ed Engl. 2009;48(20):3632-6. doi: 10.1002/anie.200806003.

PMID:
19206136
7.
8.

p53-Dependent and -independent functions of the Arf tumor suppressor.

Sherr CJ, Bertwistle D, DEN Besten W, Kuo ML, Sugimoto M, Tago K, Williams RT, Zindy F, Roussel MF.

Cold Spring Harb Symp Quant Biol. 2005;70:129-37. Review.

PMID:
16869746
9.

Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye.

Silva RL, Thornton JD, Martin AC, Rehg JE, Bertwistle D, Zindy F, Skapek SX.

EMBO J. 2005 Aug 3;24(15):2803-14. Epub 2005 Jul 21.

10.

Monoclonal antibodies to the mouse p19(Arf) tumor suppressor protein.

Bertwistle D, Zindy F, Sherr CJ, Roussel MF.

Hybrid Hybridomics. 2004 Oct;23(5):293-300.

PMID:
15672607
11.

N-terminal polyubiquitination and degradation of the Arf tumor suppressor.

Kuo ML, den Besten W, Bertwistle D, Roussel MF, Sherr CJ.

Genes Dev. 2004 Aug 1;18(15):1862-74.

12.

Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.

Bertwistle D, Sugimoto M, Sherr CJ.

Mol Cell Biol. 2004 Feb;24(3):985-96.

13.

Cell cycle and genetic background dependence of the effect of loss of BRCA2 on ionizing radiation sensitivity.

Tutt A, Connor F, Bertwistle D, Kerr P, Peacock J, Ross G, Ashworth A.

Oncogene. 2003 May 15;22(19):2926-31.

PMID:
12771943
14.

BRCA1 and BRCA2 bind Stat5a and suppress its transcriptional activity.

Vidarsson H, Mikaelsdottir EK, Rafnar T, Bertwistle D, Ashworth A, Eyfjord JE, Valgeirsdottir S.

FEBS Lett. 2002 Dec 4;532(1-2):247-52.

15.

Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences.

Tutt A, Bertwistle D, Valentine J, Gabriel A, Swift S, Ross G, Griffin C, Thacker J, Ashworth A.

EMBO J. 2001 Sep 3;20(17):4704-16.

16.

The pathology of familial breast cancer: How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology?

Bertwistle D, Ashworth A.

Breast Cancer Res. 1999;1(1):41-7. Epub 1999 Oct 27. Review.

17.

BRCA1 and BRCA2.

Bertwistle D, Ashworth A.

Curr Biol. 2000 Aug 24;10(16):R582. No abstract available.

18.

Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification.

Tutt A, Gabriel A, Bertwistle D, Connor F, Paterson H, Peacock J, Ross G, Ashworth A.

Curr Biol. 1999 Oct 7;9(19):1107-10.

19.

In situ hybridization to sections of Xenopus embryos.

Bertwistle D.

Methods Mol Biol. 1999;127:69-76. Review. No abstract available.

PMID:
10503225
20.

Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals.

Marston NJ, Richards WJ, Hughes D, Bertwistle D, Marshall CJ, Ashworth A.

Mol Cell Biol. 1999 Jul;19(7):4633-42.

21.

Functions of the BRCA1 and BRCA2 genes.

Bertwistle D, Ashworth A.

Curr Opin Genet Dev. 1998 Feb;8(1):14-20. Review.

PMID:
9529600
22.

Nuclear location and cell cycle regulation of the BRCA2 protein.

Bertwistle D, Swift S, Marston NJ, Jackson LE, Crossland S, Crompton MR, Marshall CJ, Ashworth A.

Cancer Res. 1997 Dec 15;57(24):5485-8.

23.

Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.

Connor F, Bertwistle D, Mee PJ, Ross GM, Swift S, Grigorieva E, Tybulewicz VL, Ashworth A.

Nat Genet. 1997 Dec;17(4):423-30.

PMID:
9398843
24.

Over-expression of GATA-6 in Xenopus embryos blocks differentiation of heart precursors.

Gove C, Walmsley M, Nijjar S, Bertwistle D, Guille M, Partington G, Bomford A, Patient R.

EMBO J. 1997 Jan 15;16(2):355-68. Erratum in: EMBO J 1997 Apr 1;16(7):1806-7.

25.

GATA-2 is a maternal transcription factor present in Xenopus oocytes as a nuclear complex which is maintained throughout early development.

Partington GA, Bertwistle D, Nicolas RH, Kee WJ, Pizzey JA, Patient RK.

Dev Biol. 1997 Jan 15;181(2):144-55.

26.

GATA factors and the origins of adult and embryonic blood in Xenopus: responses to retinoic acid.

Bertwistle D, Walmsley ME, Read EM, Pizzey JA, Patient RK.

Mech Dev. 1996 Jul;57(2):199-214.

27.

Negative control of Xenopus GATA-2 by activin and noggin with eventual expression in precursors of the ventral blood islands.

Walmsley ME, Guille MJ, Bertwistle D, Smith JC, Pizzey JA, Patient RK.

Development. 1994 Sep;120(9):2519-29.

Supplemental Content

Loading ...
Support Center